Akdital emerged as the most active stock in Monday’s trading session, following a significant announcement regarding its strategic collaboration with Aradei Capital. This development was reflected in Akdital’s transaction volume, which reached 11.39 million dirhams (MDH).
The Competition Council announced that it had been notified of an economic concentration project involving Aradei Capital’s acquisition of the remaining 49% of “Akdital Immo SA.” This acquisition will grant Aradei Capital exclusive control over Akdital Immo SA and its subsidiaries. These entities are engaged in the holding, acquisition, and development of real estate assets, specifically targeting long-term rental income in Morocco’s healthcare sector.
Aradei Capital had previously declared its intention to purchase the stakes held by Akdital and BFO Foncière in Akdital Immo. With a 51% stake already acquired in January 2022, Aradei Capital is now poised to obtain the additional shares from Akdital (31.85%) and BFO Foncière (17.15%). The total value of this transaction is estimated at around 268 million dirhams (MDH).
Akdital Immo, a subsidiary of the Akdital group, is dedicated to developing a portfolio of healthcare real estate assets to generate rental income. It currently holds the group’s private clinic in El Jadida and is planning to develop additional private clinics in Agadir, Tangier, Safi, and Salé.
Aradei Capital, a Moroccan real estate company specializing in rental properties, boasts a diversified portfolio of commercial, industrial, banking, and office assets across 28 cities in Morocco.
